You are here: Industry Insights > LEMS

News List

Ruzurgi Approved for Pediatric Lambert-Eaton Myasthenic Syndrome (LEMS) drugs
June 03, 2019
Ruzurgi Approved for Pediatric Lambert-Eaton Myasthenic Syndrome (LEMS).
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder fda
May 13, 2019
The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome worldpharmanews
May 10, 2019
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome.
FDA approves paediatric LEMS drug pharmaceutical-technology
May 09, 2019
The US Food and Drug Administration (FDA) has approved Jacobus Pharmaceutical’s Ruzurgi (amifampridine) as a treatment for Lambert-Eaton myasthenic syndrome (LEMS).
US Senate invites seven pharma majors to testify on price hikes pharmaceutical-technology
February 19, 2019
A US Senate committee has written to seven major pharmaceutical companies, inviting them to testify at a hearing about increases to drug prices in the country....
Catalyst sparks price row in US with $300,000 rare disease drug pharmaphorum
February 13, 2019
The controversy over rising drug prices in the US has been reignited after it emerged that the yearly cost of the life-sustaining rare disease drug Firdapse has been hiked from free to more than $300,000.
Firdapse (Amifampridine) Approved for Rare Autoimmune Disorder drugs
November 30, 2018
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).....
FDA Approves Firdapse for Rare Autoimmune Disorder drugs
November 30, 2018
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS)......
FDA Approves First Treatment for Lambert-Eaton Myasthenic Syndrome americanpharmaceuticalreview
November 30, 2018
The U.S. Food and Drug Administration (FDA) approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults....